You are here

Medicine labels: Guidance on TGO 91 and TGO 92

Version 2.1, July 2019

15 July 2019

Book pagination

Version history

Version Description of change Author Effective date
V1.0 Original publication Therapeutic Goods Administration (Scientific Evaluation Branch) 31 August 2016
V1.1

Corrections based on feedback and clarification of existing information.

Addition of latex labelling in best practice - part 3.

Addition of guidance on determining when a Schedule 1 substance is present - part 1.

Therapeutic Goods Administration (Scientific Evaluation Branch) May 2018
V2.0

Addition of information about warning statements for neuromuscular blocking agents in parts 1, 2 and 3.

Minor corrections based on stakeholder feedback.

Therapeutic Goods Administration (Scientific Evaluation Branch) June 2018
V2.1

Additional information to provide clarity on:

  • Transition period
  • Declaration of benzoates
  • Reference to the CMI for Schedule 1 declarable substances
  • Multiple barcode guidance

Minor corrections based on stakeholder feedback.

Therapeutic Goods Administration (Scientific Evaluation Branch) July 2019

Book pagination